3,541
Views
0
CrossRef citations to date
0
Altmetric
Research Article

DNA Methylation Fingerprint of Neuroblastoma Reveals New Biological and Clinical Insights

, , , , , , , , , , , , & show all
Pages 1137-1153 | Published online: 12 Jun 2015

References

  • Maris JM , HogartyMD , BagatellR , CohnSL . Neuroblastoma . Lancet369 ( 9579 ), 2106 – 2120 ( 2007 ).
  • Brodeur GM . Neuroblastoma: biological insights into a clinical enigma . Nat. Rev. Cancer.3 ( 3 ), 203 – 216 ( 2003 ).
  • Cohn SL , PearsonAD , LondonWBet al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report . J. Clin. Oncol.27 ( 2 ), 289 – 297 ( 2009 ).
  • Cheung NK , ZhangJ , LuCet al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma . JAMA307 ( 10 ), 1062 – 1071 ( 2012 ).
  • Molenaar JJ , KosterJ , ZwijnenburgDAet al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes . Nature483 ( 7391 ), 589 – 593 ( 2012 ).
  • Pugh TJ , MorozovaO , AttiyehEFet al. The genetic landscape of high-risk neuroblastoma . Nat. Genet.45 ( 3 ), 279 – 284 ( 2013 ).
  • Sausen M , LearyRJ , JonesSet al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma . Nat. Genet.45 ( 1 ), 12 – 17 ( 2013 ).
  • Smith ZD , MeissnerA . DNA methylation: roles in mammalian development . Nat. Rev. Genet.14 ( 3 ), 204 – 220 ( 2013 ).
  • Baylin SB , JonesPA . A decade of exploring the cancer epigenome – biological and translational implications . Nat. Rev. Cancer.11 ( 10 ), 726 – 734 ( 2011 ).
  • Dyachenko OV , SchevchukTV , KretznerL , BuryanovYI , SmithSS . Human non-CG methylation: are human stem cells plant-like?Epigenetics5 ( 7 ), 569 – 572 ( 2010 ).
  • Lister R , MukamelEA , NeryJRet al. Global epigenomic reconfiguration during mammalian brain development . Science341 ( 6146 ), 1237905 ( 2013 ).
  • Lister R , PelizzolaM , DowenRHet al. Human DNA methylomes at base resolution show widespread epigenomic differences . Nature462 ( 7271 ), 315 – 322 ( 2009 ).
  • Lister R , PelizzolaM , KidaYSet al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells . Nature471 ( 7336 ), 68 – 73 ( 2011 ).
  • Ramsahoye BH , BiniszkiewiczD , LykoF , ClarkV , BirdAP , JaenischR . Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a . Proc. Natl Acad. Sci. USA97 ( 10 ), 5237 – 5242 ( 2000 ).
  • Hon GC , RajagopalN , ShenYet al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues . Nat. Genet.45 ( 10 ), 1198 – 1206 ( 2013 ).
  • Kreck B , RichterJ , AmmerpohlOet al. Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing . Leukemia27 ( 8 ), 1751 – 1753 ( 2013 ).
  • Berman BP , WeisenbergerDJ , AmanJFet al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains . Nat. Genet.44 ( 1 ), 40 – 46 ( 2012 ).
  • Kulis M , QueirosAC , BeekmanR , Martin-SuberoJI . Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer . Biochim. Biophys. Acta1829 ( 11 ), 1161 – 1174 ( 2013 ).
  • Truong M , YangB , WagnerJ , DesotelleJ , JarrardDF . Analysis of promoter non-CG methylation in prostate cancer . Epigenomics5 ( 1 ), 65 – 71 ( 2013 ).
  • Yang Q , KiernanCM , TianYet al. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome . Clin. Cancer. Res.13 ( 11 ), 3191 – 3197 ( 2007 ).
  • Abe M , WestermannF , NakagawaraA , TakatoT , SchwabM , UshijimaT . Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas . Cancer. Lett.247 ( 2 ), 253 – 258 ( 2007 ).
  • Banelli B , BrigatiC , Di VinciAet al. A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype . Lab. Invest.92 ( 3 ), 458 – 465 ( 2012 ).
  • Asada K , WatanabeN , NakamuraYet al. Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas . Japanese J. Clin. Oncol.43 ( 6 ), 641 – 645 ( 2013 ).
  • Koyama H , ZhuangT , LightJEet al. Mechanisms of CHD5 inactivation in neuroblastomas . Clin. Cancer. Res.18 ( 6 ), 1588 – 1597 ( 2012 ).
  • Hoebeeck J , MichelsE , PattynFet al. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma . Cancer. Lett.273 ( 2 ), 336 – 346 ( 2009 ).
  • Haruta M , KamijoT , NakagawaraA , KanekoY . RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients . Cancer. Lett.348 ( 1–2 ), 167 – 176 ( 2014 ).
  • Teitz T , WeiT , ValentineMBet al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN . Nat. Med.6 ( 5 ), 529 – 535 ( 2000 ).
  • Yanez Y , GrauE , Rodriguez-CortezVCet al. Two independent epigenetic biomarkers predict survival in neuroblastoma . Clin. Epigenetics7 ( 1 ), 16 ( 2015 ).
  • Dreidax D , BannertS , HenrichKOet al. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas . Hum. Mol. Genet.23 ( 25 ), 6826 – 6837 ( 2014 ).
  • Brodeur GM , PritchardJ , BertholdFet al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment . J. Clin. Oncol.11 ( 8 ), 1466 – 1477 ( 1993 ).
  • Lavarino C , GarciaI , MackintoshCet al. Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status . BMC Med. Genomics1 , 36 ( 2008 ).
  • Bagci O , TumerS , OlgunN , AltungozO . Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors . Cancer Lett.317 ( 1 ), 72 – 77 ( 2012 ).
  • Garcia I , MayolG , RiosJet al. A three-gene expression signature model for risk stratification of patients with neuroblastoma . Clin. Cancer Res.18 ( 7 ), 2012 – 2023 ( 2012 ).
  • Bibikova M , BarnesB , TsanCet al. High density DNA methylation array with single CpG site resolution . Genomics98 ( 4 ), 288 – 295 ( 2011 ).
  • Nazor KL , AltunG , LynchCet al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives . Cell Stem Cell10 ( 5 ), 620 – 634 ( 2012 ).
  • Kent WJ , SugnetCW , FureyTSet al. The human genome browser at UCSC . Genome Res.12 ( 6 ), 996 – 1006 ( 2002 ).
  • Roadmap Epigenomics C , KundajeA , MeulemanWet al. Integrative analysis of 111 reference human epigenomes . Nature518 ( 7539 ), 317 – 330 ( 2015 ).
  • Mayol G , Martin-SuberoJI , RiosJet al. DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis . PLoS ONE7 ( 11 ), e48401 ( 2012 ).
  • Gautier L , CopeL , BolstadBM , IrizarryRA . affy‐analysis of Affymetrix GeneChip data at the probe level . Bioinformatics20 ( 3 ), 307 – 315 ( 2004 ).
  • Garcia I , MayolG , RodriguezEet al. Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma . Mol. Cancer9 , 277 ( 2010 ).
  • Kulis M , HeathS , BibikovaMet al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia . Nat. Genet.44 ( 11 ), 1236 – 1242 ( 2012 ).
  • Chan TA , GlocknerS , YiJMet al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis . PLoS. Med.5 ( 5 ), e114 ( 2008 ).
  • Okawa ER , GotohT , ManneJet al. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas . Oncogene27 ( 6 ), 803 – 810 ( 2008 ).
  • Aran D , HellmanA . DNA methylation of transcriptional enhancers and cancer predisposition . Cell154 ( 1 ), 11 – 13 ( 2013 ).
  • Guo JU , SuY , ShinJHet al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain . Nat. Neurosci.17 ( 2 ), 215 – 222 ( 2014 ).
  • Esteller M . Epigenetics in cancer . N. Engl. J. Med.358 ( 11 ), 1148 – 1159 ( 2008 ).
  • Ball MP , LiJB , GaoYet al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells . Nat. Biotechnol.27 ( 4 ), 361 – 368 ( 2009 ).
  • Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond . Nat. Rev. Genet.13 ( 7 ), 484 – 492 ( 2012 ).
  • Kozlenkov A , RoussosP , TimashpolskyAet al. Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites . Nucleic Acids Res.42 ( 1 ), 109 – 127 ( 2014 ).
  • Mosse YP , LaudenslagerM , LongoLet al. Identification of ALK as a major familial neuroblastoma predisposition gene . Nature455 ( 7215 ), 930 – 935 ( 2008 ).
  • Caren H , AbelF , KognerP , MartinssonT . High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours . Biochem. J.416 ( 2 ), 153 – 159 ( 2008 ).
  • George RE , SandaT , HannaMet al. Activating mutations in ALK provide a therapeutic target in neuroblastoma . Nature455 ( 7215 ), 975 – 978 ( 2008 ).
  • Carpenter EL , MosseYP . Targeting ALK in neuroblastoma – preclinical and clinical advancements . Nat. Rev. Clin. Oncol.9 ( 7 ), 391 – 399 ( 2012 ).
  • Passoni L , LongoL , ColliniPet al. Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients . Cancer Res.69 ( 18 ), 7338 – 7346 ( 2009 ).
  • Schuebel KE , ChenW , CopeLet al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer . PLoS Genet.3 ( 9 ), 1709 – 1723 ( 2007 ).
  • Molenaar JJ , EbusME , KosterJet al. Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells . Oncogene29 ( 18 ), 2739 – 2745 ( 2010 ).
  • Wang Y , RaoVK , KokWKet al. SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest . PLoS ONE7 ( 8 ), e43137 ( 2012 ).
  • French JD , GhoussainiM , EdwardsSLet al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers . Am. J. Hum. Genet.92 ( 4 ), 489 – 503 ( 2013 ).
  • Suzuki H , YamamotoE , MaruyamaR , NiinumaT , KaiM . Biological significance of the CpG island methylator phenotype . Biochem. Biophys. Res. Commun.455 ( 1–2 ), 35 – 42 ( 2014 ).
  • GEO Expression Omnibus . http://www.ncbi.nlm.nih.gov/geo/ .
  • Lavarino C . DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma . www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token .
  • Lavarino C . DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma [methylation] . http://www.ncbi.nlm.nih.gov/geo/query .
  • Lavarino C . DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma [gene expression] . http://www.ncbi.nlm.nih.gov/geo/query .